Portfolio
Capricorn Cleantech
Advancing green chemistry, the circular economy and carbon-neutrality
-
REIN4CED
-
VOID
-
FRX Innovations
Quest Cleantech
Enabling a cleaner and more efficient use of our natural resources
-
Andritz
-
DEME
-
Melexis
Quest for Growth
Integrating quoted and private investments
-
Capricorn Chemistry Fund
-
The Carlyle Group
-
Fruitcore Robotics
Capricorn Digital
From data to actionable insights
-
Noona
-
Sensolus
-
EclecticIQ
Capricorn Fusion
Focused on providing growth capital to Small and Medium-sized Enterprises (SME) in Europe and Asia
-
Spectricity
-
Finquest
-
XenomatiX
Capricorn Health
Enabling personalized care, promoting value-based health
-
Cartagenia
-
Ogeda
exited
Sector
Pharma & Biotech
Headquarters
Belgium
Portfolio entry
2016: Capricorn Healthtech Fund I
Exit
2017
Clinical-stage drug discovery
Ogeda is a drug development company with a chemistry service business focusing on discovery of small molecules targeting GPCRs. The companies’ lead program for the non-hormonal treatment of hot flashes is addressing a huge issue for woman worldwide and attracted the attention of Japanese based Astellas
The investment illustrates the fund’s belief that purpose-driven R&D companies within healthcare are critical for developing novel solutions to improve the quality of life of people. The company was successfully sold to Astellas for a purchase price of €500 million plus milestones.
-
Diagenode
